Boston Common Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $26.9M | Sell |
|
|||||
|
2025
Q2 | $27.9M | Buy |
|
|||||
|
2025
Q1 | $22.5M | Buy |
|
|||||
|
2024
Q4 | $18.5M | Buy |
|
|||||
|
2024
Q3 | $16.4M | Buy |
|
|||||
|
2024
Q2 | $9.47M | Buy |
|
|||||
|
2024
Q1 | $7.67M | Sell |
|
|||||
|
2023
Q4 | $5.89M | Sell |
|
|||||
|
2023
Q3 | $5.58M | Buy |
|
|||||
|
2023
Q2 | $2.88M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.03M | Buy |
|
|||||
|
2022
Q3 | $892K | Buy |
|
|||||
|
2022
Q2 | $883K | Buy |
|
|||||
|
2022
Q1 | $713K | Sell |
|
|||||
|
2021
Q4 | $770K | Buy |
|
|||||
|
2021
Q3 | $610K | Buy |
|
|||||
|
2021
Q2 | $604K | Buy |
|
|||||
|
2021
Q1 | $457K | Buy |
|
|||||
|
2020
Q4 | $409K | Buy |
|